Investors

Magen BioSciences is backed by prominent angel investors and the leading venture capital firms listed below.

Highland Capital Partners
Highland Capital Partners was founded with the mission of helping great people build great companies. Since its inception in 1988, the firm has taken a sector-focused approach to investing in exceptional information technology, communications and healthcare companies. With more than $2.6 billion of committed capital, Highland has invested in and worked to create such firms as Altiga Networks, Ask Jeeves, Avid Technology, Be Free, CheckFree, Conor Medsystems, Continental Cable, Lycos, MapQuest, New Oak Communications, Ocular Networks, Sybase, Telica, VistaPrint and WebLine Communications. For more information, visit Highland's web site at www.hcp.com.

Venrock Associates
Venrock was founded as the venture capital arm of the Rockefeller Family and continues a six-decade tradition of funding outstanding entrepreneurs and establishing successful, enduring companies. Venrock was formed in 1969 to build upon the successful investing activities of the Rockefeller Family that began in the late 1930s, when Laurance Rockefeller pioneered early-stage venture financing. Today, having invested more than $1.3 billion into 360 companies over the past 34 years, Venrock is one of the most established venture firms in the United States, with investment returns that place it among a small number of premier organizations that have achieved consistently superior performance. For more information, visit Venrock Associates' web site at www.venrock.com.

ARCH Venture Partners
ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in information technology, life sciences, and physical sciences. We enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. For more information, visit ARCH Venture Partners' web site at www.archventure.com.

TVM Capital
TVM Capital (formerly Techno Venture Management) was founded in 1983 as one of the first venture capital firms formed in Germany, and an early entrant into the US market in 1986. Since inception TVM Capital has raised over €1.3 billion (approximately $1.6 billion) in six fund generations and has established itself as a leading technology investment group in the United States and Europe. TVM Capital funds have made investments in more than 220 life sciences and information technology companies where innovation, effective management and sound financial backing have enormous impact on company growth. TVM Capital’s in-depth knowledge of the U.S. and European environments helps companies create businesses that enjoy access to science, management talent, distribution channels and capital on both sides of the Atlantic. More than 40 companies have gone public at European or US stock exchanges. Today, TVM Capital is actively invested in more than 60 companies. For more information, visit TVM Capital's web site at www.tvm-capital.com.

Lux Capital
Lux Capital is a research-driven investment firm focused on building businesses of lasting value. Lux uncovers and creates market-leading companies by leveraging our vast network, proprietary business intelligence and unique access. Lux’s investment strategy ensures our portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competitors. Lux Capital is credited with introducing the first investment framework for nanotechnology adopted by other venture capital funds and top-tier Wall Street investment banks. Lux’s reputation and expertise has led to relationships with these leading private-equity firms and investment banks that serve as sources of syndicate investment partners, follow-on financing, and exit opportunities for the entrepreneurs we invest in. Some of Lux’s syndicate and co-investment partners have included Intel, Motorola, Genentech, Eastman Kodak, KLA-Tencor, In-Q-Tel (C.I.A.), Venrock Associates, Polaris Venture Partners, ARCH Venture Partners, Oxford BioSciences and Alloy Ventures. For more information, visit Lux Capital's web site at www.luxcapital.com.

Flybridge Capital Partners
Flybridge Capital Partners is an early-stage venture capital firm whose mission is to assist talented entrepreneurs in growing innovative, global companies. With $560 million under management, the firm is focused on investing in consumer, healthcare and information technology markets and is led by a team with domain expertise and more than half a century of combined experience in venture capital. For more information, visit www.flybridge.com.

QVT Financial LP